Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Efficacy of osimertinib against EGFRvIII+ glioblastoma.
Oncotarget. 2020 Jun 2;11(22):2074-2082. doi: 10.18632/oncotarget.27599. eCollection 2020 Jun 2.
Oncotarget. 2020.
PMID: 32547705
Free PMC article.
GZ17-6.02 Inhibits the Growth of EGFRvIII+ Glioblastoma.
Choi J, Bordeaux ZA, McKeel J, Nanni C, Sutaria N, Braun G, Davis C, Miller MN, Alphonse MP, Kwatra SG, West CE, Kwatra MM.
Choi J, et al.
Int J Mol Sci. 2022 Apr 10;23(8):4174. doi: 10.3390/ijms23084174.
Int J Mol Sci. 2022.
PMID: 35456993
Free PMC article.
Item in Clipboard
Proteomic and Phosphoproteomic Analysis Reveals that Neurokinin-1 Receptor (NK1R) Blockade with Aprepitant in Human Keratinocytes Activates a Distinct Subdomain of EGFR Signaling: Implications for the Anti-Pruritic Activity of NK1R Antagonists.
Kwatra SG, Boozalis E, Huang AH, Nanni C, Khanna R, Williams KA, Semenov YR, Roberts CM, Burns RF, Krischak M, Kwatra MM.
Kwatra SG, et al.
Medicines (Basel). 2019 Dec 9;6(4):114. doi: 10.3390/medicines6040114.
Medicines (Basel). 2019.
PMID: 31835310
Free PMC article.
Item in Clipboard
Cite
Cite